We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




US Regulation Would Require Bar Codes on All Drugs

By HospiMedica staff writers
Posted on 24 Mar 2003
As part of a sweeping new three-part program to reduce medication errors and improve patient safety, the US Food and Drug Administration (FDA, Washington, DC, USA) has proposed a new regulation that would require bar codes on all prescription drugs.

The new regulation would apply to all over-the-counter drugs packaged for hospital use, vaccines, and blood and blood components. More...
At a minimum, the bar code would contain the drug's National Drug Code number, which identifies the drug, its strength, and its dosage form. The FDA is also considering whether to include lot number and expiration date. The agency estimates that the bar code rule will result in a 50% increase in the interception of medication errors at the dispensing and administration stages. In a study at a US Veterans Affairs Medical Center, 5.7 million doses of medication were administered to patients with no errors when a bar code scanning medication dispensing system was used.

A bar-coded identification bracelet will link patients to their computerized medical record. Before administering a drug, a healthcare worker would scan the patient's computerized record, then scan the drugs provided by the pharmacy for the patient. The computer compares the patient's medical record to the drug(s) being administered to ensure they match what is prescribed for the patient. If they do not, the computer sends an error message and the problem is investigated. The regulation is designed to prevent problems such as the wrong drug, the wrong dose, the wrong time to administer the drug, or a change in the patient's medication.

Along with this regulation, the FDA has proposed new rules governing the reporting of safety information. These were developed jointly with authorities in the pharmaceutical and biologic industry and regulatory authorities in the European Union, Canada, Switzerland, and Japan to improve the quality and consistency of safety information reporting. Other new rules would require expedited reporting of suspected adverse drug reactions (SADR) that are serious and unexpected, new safety findings from clinical studies, and improved data in all reporting.

These proposals are part of a new framework of FDA programs to identify and manage safety problems associated with regulated medical products, using modern information technology, partnerships with healthcare organizations, and more-effective communication tools. Automatic, real-time transmission of safety data from healthcare systems will be an important part of these programs.




Related Links:
FDA

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Warming Cabinet
EC1850BL
New
Hospital Stretcher
Millennium 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.